Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $138.35 USD
Change Today +0.95 / 0.69%
Volume 273.6K
USNA On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

usana health sciences inc (USNA) Snapshot

Open
$138.31
Previous Close
$137.40
Day High
$140.69
Day Low
$135.44
52 Week High
08/5/15 - $176.88
52 Week Low
09/25/14 - $69.76
Market Cap
1.8B
Average Volume 10 Days
189.9K
EPS TTM
$6.54
Shares Outstanding
12.8M
EX-Date
--
P/E TM
21.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for USANA HEALTH SCIENCES INC (USNA)

usana health sciences inc (USNA) Related Bloomberg News

View More Bloomberg News

usana health sciences inc (USNA) Related Businessweek News

No Related Businessweek News Found

usana health sciences inc (USNA) Details

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease worldwide. The company offers USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools, such as associate starter kit and product brochures to assist associates in building their businesses and in marketing products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

1,527 Employees
Last Reported Date: 03/17/15
Founded in 1992

usana health sciences inc (USNA) Top Compensated Officers

Co-Chief Executive Officer and President
Total Annual Compensation: $614.8K
Co-Chief Executive Officer
Total Annual Compensation: $469.2K
Founder and Chairman
Total Annual Compensation: --
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $329.5K
President of Asia & Greater China
Total Annual Compensation: $583.5K
Compensation as of Fiscal Year 2014.

usana health sciences inc (USNA) Key Developments

USANA Health Sciences Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended July 4, 2015; Revises Earnings Guidance for the Year 2015

USANA Health Sciences Inc. reported unaudited consolidated earnings results for the second quarter and six months ended July 4, 2015. For the quarter, the company reported net sales of $233,244,000 against $188,256,000 a year ago. Earnings from operations were $38,773,000 against $29,087,000 a year ago. Earnings before income taxes were $38,687,000 against $29,384,000 a year ago. Net earnings were $25,416,000 or $1.92 per dilute share against $19,301,000 or $1.36 per dilute share a year ago. For the second quarter of 2015, net sales increased 23.9% compared with $188.3 million in the prior-year period. The increase in Net Sales were driven by 40.3% growth in the number of active Associates and 15.2% growth in the number of Preferred Customers. Also included in net sales for the quarter is $5 million in revenue that was deferred during the previous quarter in connection with price increases in China. The increase in net earnings was driven by higher net sales, improved gross margins and lower relative selling, general and administrative expense, which were partially offset by higher relative Associate Incentives expense. The increase in earnings per share was attributable to higher net earnings and a lower number of diluted shares outstanding due to the Company's share repurchases during 2014. For the six months, the company reported net sales of $452,622,000 against $370,657,000 a year ago. Earnings from operations were $38,773,000 against $29,087,000 a year ago. Earnings before income taxes were $68,559,000 against $54,209,000 a year ago. Net earnings were $45,096,000 or $3.43 per dilute share against $35,838,000 or $2.50 per dilute share a year ago. For the year 2015, the company expects consolidated net sales between $900 million and $920 million, versus the previous outlook of between $870 million and $890 million. Earnings per share between $6.90 and $7.20, versus the previous outlook of between $6.45 and $6.75. The company expects that earnings from operations will be around 15.5% of net sales at the high-end of net sales range. Associate Incentives expense of 44.0% to 44.5% of net sales for the remainder of 2015. Planned capital spending of approximately $45 million for new facility in China, branch upgrades, and investments in personalization initiative and information technology infrastructure. An effective tax rate of approximately 34% for the full-year. Continued headwinds from a strengthening U.S. dollar; and diluted share count of approximately 13 million shares.

USANA Health Sciences, Inc. Announces Management Changes

USANA Health Sciences Inc. announced that the Board of Directors has appointed Dave Wentz and Kevin Guest as Co-Chief Executive Officers of the company, effective immediately. Mr. Wentz will oversee USANA’s global operations, while Mr. Guest will lead USANA’s worldwide field development and sales efforts. Both Mr. Guest and Mr. Wentz will report directly to the Board of Directors. The company also reported that Paul Jones, Chief Financial Officer, has been appointed Chief Leadership Development Officer, where he will be responsible for the key role of overseeing USANA’s global executive development and succession planning program. Mr. Jones will continue his CFO responsibilities while the company initiates a search for a new Chief Financial Officer.

USANA Health Sciences Inc. to Report Q2, 2015 Results on Aug 04, 2015

USANA Health Sciences Inc. announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Aug 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
USNA:US $138.35 USD +0.95

USNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Helen of Troy Ltd $84.77 USD +0.98
Inter Parfums Inc $25.04 USD +0.02
Nutrisystem Inc $27.88 USD -0.04
Vitamin Shoppe Inc $34.90 USD +0.20
WD-40 Co $84.38 USD +0.43
View Industry Companies
 

Industry Analysis

USNA

Industry Average

Valuation USNA Industry Range
Price/Earnings 21.0x
Price/Sales 2.0x
Price/Book 6.2x
Price/Cash Flow 20.5x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact USANA HEALTH SCIENCES INC, please visit www.usanahealthsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.